cytarabine and sphingosine

cytarabine has been researched along with sphingosine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bittman, R; Dent, P; Erukulla, RK; Fornari, FA; Grant, S; Jarvis, WD; Schwartz, GK; Tombes, RM1
Blanco-Prieto, MJ; Castello-Cros, R; Cirauqui, C; Estella-Hermoso de Mendoza, A; Imbuluzqueta, E; Odero, MD; Pippa, R1

Other Studies

2 other study(ies) available for cytarabine and sphingosine

ArticleYear
Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling.
    Molecular pharmacology, 1998, Volume: 54, Issue:5

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Bryostatins; Calcium-Calmodulin-Dependent Protein Kinases; Cytarabine; Diglycerides; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Flavonoids; HL-60 Cells; Humans; Lactones; Macrolides; Protein Kinase Inhibitors; Protein Kinases; Signal Transduction; Sphingosine; Stereoisomerism

1998
Lipid Nanosystems Enhance the Bioavailability and the Therapeutic Efficacy of FTY720 in Acute Myeloid Leukemia.
    Journal of biomedical nanotechnology, 2015, Volume: 11, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Proliferation; Cytarabine; Drug Delivery Systems; Enzyme Activation; Female; Fingolimod Hydrochloride; HL-60 Cells; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lipids; Mice; Mice, Transgenic; Nanoparticles; Nanotechnology; Propylene Glycols; Sphingosine

2015